Development and Implementation of an Evidence-Based Educational Program on Hyperglycemia in Cancer Patients for Registered Nurses

October 2016 Vol 7, No 9
Veronica Sampayo, RN, BSN
Doctor of Nursing Practice Student University of South Florida

Objectives: The purpose of this evidence-based project was to increase nurse knowledge and awareness of the consequences of hyperglycemia in cancer patients, thereby increasing their capability to effectively intervene. Additionally, a clinical algorithm based on current evidence was developed and provided for participants of the program.

Methods: A 2-hour innovative educational program was developed and piloted at the University of Florida (UF) Health Cancer Center at Orlando Health. This program addressed the etiology of hyperglycemia and its effects on cancer patients. Knowledge of hyperglycemia in oncology patients was assessed with a test before and after participation in the educational program. Results were disseminated to the UF Health Cancer Center’s learning specialist team for consideration of incorporation into the oncology nurses’ educational plan.

Results: Overall, 100% of participants found the educational program “very effective” and deemed the clinical algorithm “very useful.” Using a paired sample t test, there was a significant improvement in scores from pretest (M = 63%) to posttest (M = 80%) (P <.001). Overall, mean scores on the postintervention survey increased by 17%.

Conclusions: Development of hyperglycemia during cancer treatment increases the risk of permanent diabetes in cancer survivors. Oncology nurses should be able to recognize complications associated with cancer and cancer treatment, including hyperglycemia. They should be capable of educating cancer patients about the possible effects of hyperglycemia and self-management strategies. By increasing nurse knowledge and awareness, through continuing education, oncology nurses will become more confident and empowered to provide timely interventions in cancer patients and improve overall outcomes. Nurses should utilize evidence-based strategies to incorporate nursing interventions in hyperglycemic cancer patients.

Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country